Antiglaucoma Drugs Global Market Report 2025

Antiglaucoma Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antiglaucoma drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for antiglaucoma drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antiglaucoma drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Hospital Prescription Drugs; Over-The Counter Drugs

2) By Product Type: Alpha Agonist; Beta Blockers; Prostaglandin Analogs; Combined Medication; Other Types

3) By Disease Condition Type: Open-Angle Glaucoma; Angle-Closure Glaucoma; Normal-Tension Glaucoma; Congenital Glaucoma; Other Types Of Glaucoma

Subsegments:

1) By Hospital Prescription Drugs: Beta-Blockers (Timolol); Prostaglandin Analogs (Latanoprost); Alpha Agonists (Brimonidine); Carbonic Anhydrase Inhibitors (Dorzolamide); Rho Kinase Inhibitors (Netarsudil)

2) By Over-The-Counter Drugs: Artificial Tears; Eye Drops For IOP Reduction; Herbal And Natural Remedies

Companies Mentioned: Aerie Pharmaceuticals Inc.; Allergan Inc.; Novartis AG; Abbott Healthcare Pvt. Ltd.; Johnson & Johnson

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Antiglaucoma Drugs Market Characteristics
3. Antiglaucoma Drugs Market Trends And Strategies
4. Antiglaucoma Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Antiglaucoma Drugs Growth Analysis And Strategic Analysis Framework
5.1. Global Antiglaucoma Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Antiglaucoma Drugs Market Growth Rate Analysis
5.4. Global Antiglaucoma Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Antiglaucoma Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Antiglaucoma Drugs Total Addressable Market (TAM)
6. Antiglaucoma Drugs Market Segmentation
6.1. Global Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Prescription Drugs
Over-The-Counter Drugs
6.2. Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alpha Agonist
Beta Blockers
Prostaglandin Analogs
Combined Medication
Other Types
6.3. Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Open-Angle Glaucoma
Angle-Closure Glaucoma
Normal-Tension Glaucoma
Congenital Glaucoma
Other Types Of Glaucoma
6.4. Global Antiglaucoma Drugs Market, Sub-Segmentation Of Hospital Prescription Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Beta-Blockers (Timolol)
Prostaglandin Analogs (Latanoprost)
Alpha Agonists (Brimonidine)
Carbonic Anhydrase Inhibitors (Dorzolamide)
Rho Kinase Inhibitors (Netarsudil)
6.5. Global Antiglaucoma Drugs Market, Sub-Segmentation Of Over-The-Counter Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Artificial Tears
Eye Drops For IOP Reduction
Herbal And Natural Remedies
7. Antiglaucoma Drugs Market Regional And Country Analysis
7.1. Global Antiglaucoma Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Antiglaucoma Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Antiglaucoma Drugs Market
8.1. Asia-Pacific Antiglaucoma Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Antiglaucoma Drugs Market
9.1. China Antiglaucoma Drugs Market Overview
9.2. China Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Antiglaucoma Drugs Market
10.1. India Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Antiglaucoma Drugs Market
11.1. Japan Antiglaucoma Drugs Market Overview
11.2. Japan Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Antiglaucoma Drugs Market
12.1. Australia Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Antiglaucoma Drugs Market
13.1. Indonesia Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Antiglaucoma Drugs Market
14.1. South Korea Antiglaucoma Drugs Market Overview
14.2. South Korea Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Antiglaucoma Drugs Market
15.1. Western Europe Antiglaucoma Drugs Market Overview
15.2. Western Europe Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Antiglaucoma Drugs Market
16.1. UK Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Antiglaucoma Drugs Market
17.1. Germany Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Antiglaucoma Drugs Market
18.1. France Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Antiglaucoma Drugs Market
19.1. Italy Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Antiglaucoma Drugs Market
20.1. Spain Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Antiglaucoma Drugs Market
21.1. Eastern Europe Antiglaucoma Drugs Market Overview
21.2. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Antiglaucoma Drugs Market
22.1. Russia Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Antiglaucoma Drugs Market
23.1. North America Antiglaucoma Drugs Market Overview
23.2. North America Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Antiglaucoma Drugs Market
24.1. USA Antiglaucoma Drugs Market Overview
24.2. USA Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Antiglaucoma Drugs Market
25.1. Canada Antiglaucoma Drugs Market Overview
25.2. Canada Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Antiglaucoma Drugs Market
26.1. South America Antiglaucoma Drugs Market Overview
26.2. South America Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Antiglaucoma Drugs Market
27.1. Brazil Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Antiglaucoma Drugs Market
28.1. Middle East Antiglaucoma Drugs Market Overview
28.2. Middle East Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Antiglaucoma Drugs Market
29.1. Africa Antiglaucoma Drugs Market Overview
29.2. Africa Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Antiglaucoma Drugs Market Competitive Landscape And Company Profiles
30.1. Antiglaucoma Drugs Market Competitive Landscape
30.2. Antiglaucoma Drugs Market Company Profiles
30.2.1. Aerie Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Allergan Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Abbott Healthcare Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
31. Antiglaucoma Drugs Market Other Major And Innovative Companies
31.1. Merck & Co.
31.2. Genentech Inc.
31.3. Pfizer Inc.
31.4. Bayer AG
31.5. Santen Pharmaceuticals Company Ltd.
31.6. Regeneron Pharmaceuticals Inc.
31.7. Valeant Pharmaceuticals International Inc.
31.8. F. Hoffmann-La Roche Ltd.
31.9. Hoya Corporation
31.10. Bausch + Lomb Inc.
31.11. Fera Pharmaceuticals LLC
31.12. Thea Pharma Inc.
31.13. Alcon AG
31.14. Teva Pharmaceutical Industries Ltd.
31.15. Sun Pharmaceutical Industries Ltd.
32. Global Antiglaucoma Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Antiglaucoma Drugs Market
34. Recent Developments In The Antiglaucoma Drugs Market
35. Antiglaucoma Drugs Market High Potential Countries, Segments and Strategies
35.1 Antiglaucoma Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Antiglaucoma Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Antiglaucoma Drugs Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings